ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy

Julie Cowie, Kevin Swingler, Clare Leadbetter, Roma Maguire, Kathryn McCall, Nora Kearney

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences of patients, information about potential side-effects may also be of significant benefit clinically, as patients who are ‘at risk’ of developing certain toxicities may be identified, facilitating more targeted, cost-effective interventions. This paper describes research which uses risk modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool SERAT (Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.
Original languageEnglish
Title of host publicationProceedings of the First International Conference on Health Informatics (Volume 2)
EditorsLuis Azevedo, Ana Londrai
PublisherSciTePress
Pages225-230
Number of pages6
ISBN (Print)9789898111166
DOIs
Publication statusPublished - 30 Nov 2007

Fingerprint

Drug Therapy
Neoplasms
Software
Costs and Cost Analysis
Therapeutics
Research

Keywords

  • Risk modelling
  • side-effect prediction
  • cancer
  • chemotherapy
  • Cancer Chemotherapy
  • Cancer Research
  • Health risk assessment

Cite this

Cowie, J., Swingler, K., Leadbetter, C., Maguire, R., McCall, K., & Kearney, N. (2007). ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy. In L. Azevedo, & A. Londrai (Eds.), Proceedings of the First International Conference on Health Informatics (Volume 2) (pp. 225-230). SciTePress. https://doi.org/10.5220/0001044502250230
Cowie, Julie ; Swingler, Kevin ; Leadbetter, Clare ; Maguire, Roma ; McCall, Kathryn ; Kearney, Nora. / ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy. Proceedings of the First International Conference on Health Informatics (Volume 2). editor / Luis Azevedo ; Ana Londrai. SciTePress, 2007. pp. 225-230
@inproceedings{61b7b6a338ab4b4c8602d739c0a50a25,
title = "ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy",
abstract = "Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences of patients, information about potential side-effects may also be of significant benefit clinically, as patients who are ‘at risk’ of developing certain toxicities may be identified, facilitating more targeted, cost-effective interventions. This paper describes research which uses risk modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool SERAT (Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.",
keywords = "Risk modelling, side-effect prediction, cancer, chemotherapy, Cancer Chemotherapy, Cancer Research, Health risk assessment",
author = "Julie Cowie and Kevin Swingler and Clare Leadbetter and Roma Maguire and Kathryn McCall and Nora Kearney",
year = "2007",
month = "11",
day = "30",
doi = "10.5220/0001044502250230",
language = "English",
isbn = "9789898111166",
pages = "225--230",
editor = "Luis Azevedo and Ana Londrai",
booktitle = "Proceedings of the First International Conference on Health Informatics (Volume 2)",
publisher = "SciTePress",

}

Cowie, J, Swingler, K, Leadbetter, C, Maguire, R, McCall, K & Kearney, N 2007, ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy. in L Azevedo & A Londrai (eds), Proceedings of the First International Conference on Health Informatics (Volume 2). SciTePress, pp. 225-230. https://doi.org/10.5220/0001044502250230

ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy. / Cowie, Julie; Swingler, Kevin; Leadbetter, Clare; Maguire, Roma; McCall, Kathryn; Kearney, Nora.

Proceedings of the First International Conference on Health Informatics (Volume 2). ed. / Luis Azevedo; Ana Londrai. SciTePress, 2007. p. 225-230.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy

AU - Cowie, Julie

AU - Swingler, Kevin

AU - Leadbetter, Clare

AU - Maguire, Roma

AU - McCall, Kathryn

AU - Kearney, Nora

PY - 2007/11/30

Y1 - 2007/11/30

N2 - Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences of patients, information about potential side-effects may also be of significant benefit clinically, as patients who are ‘at risk’ of developing certain toxicities may be identified, facilitating more targeted, cost-effective interventions. This paper describes research which uses risk modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool SERAT (Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.

AB - Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences of patients, information about potential side-effects may also be of significant benefit clinically, as patients who are ‘at risk’ of developing certain toxicities may be identified, facilitating more targeted, cost-effective interventions. This paper describes research which uses risk modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool SERAT (Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.

KW - Risk modelling

KW - side-effect prediction

KW - cancer

KW - chemotherapy

KW - Cancer Chemotherapy

KW - Cancer Research

KW - Health risk assessment

U2 - 10.5220/0001044502250230

DO - 10.5220/0001044502250230

M3 - Conference contribution

SN - 9789898111166

SP - 225

EP - 230

BT - Proceedings of the First International Conference on Health Informatics (Volume 2)

A2 - Azevedo, Luis

A2 - Londrai, Ana

PB - SciTePress

ER -

Cowie J, Swingler K, Leadbetter C, Maguire R, McCall K, Kearney N. ASYMS-SERAT: a side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy. In Azevedo L, Londrai A, editors, Proceedings of the First International Conference on Health Informatics (Volume 2). SciTePress. 2007. p. 225-230 https://doi.org/10.5220/0001044502250230